PEAK6 Group’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-12,600
Closed -$2.41M 4607
2018
Q1
$2.41M Buy
12,600
+5,600
+80% +$1.03M 0.01% 1233
2017
Q4
$1.09M Buy
7,000
+1,300
+23% +$205K 0.01% 1845
2017
Q3
$886K Sell
5,700
-3,200
-36% -$506K ﹤0.01% 2062
2017
Q2
$1.44M Buy
8,900
+400
+5% +$65K 0.01% 1616
2017
Q1
$1.31M Sell
8,500
-1,200
-12% -$165K 0.01% 1466
2016
Q4
$1.14M Sell
9,700
-9,800
-50% -$1.12M 0.01% 1749
2016
Q3
$2.2M Buy
19,500
+14,300
+275% +$1.51M 0.02% 1216
2016
Q2
$483K Sell
5,200
-8,700
-63% -$747K ﹤0.01% 2383
2016
Q1
$1.09M Sell
13,900
-12,400
-47% -$893K 0.01% 1595
2015
Q4
$1.92M Buy
26,300
+8,600
+49% +$613K 0.01% 1381
2015
Q3
$1.31M Buy
17,700
+15,900
+883% +$1.14M 0.01% 1939
2015
Q2
$115K Buy
1,800
+600
+50% +$41.5K ﹤0.01% 4170
2015
Q1
$93K Sell
1,200
-2,800
-70% -$218K ﹤0.01% 3985
2014
Q4
$297K Buy
+4,000
New +$281K ﹤0.01% 3035
2014
Q1
Sell
-4,000
Closed -$213K 5122
2013
Q4
$213K Buy
+4,000
New +$211K ﹤0.01% 3467
2013
Q3
Sell
-31,200
Closed -$1.4K 5278
2013
Q2
$1.4K Buy
+31,200
New +$1.36M 0.01% 1848

Other funds holding IDXX

PEAK6 Group's IDXX Position: Q2 2018 in Review

PEAK6 Group increased its Idexx Laboratories (IDXX) stake by 1.2% in Q2 2018, buying an estimated $17.5K and bringing the position to 7,032 shares worth $1.53M. The position accounts for 0.01% of the portfolio, ranked #1589.

PEAK6 Group first reported a position in IDXX in Q2 2013 and has held it in 9 quarters since. 664 funds tracked by Wall St. Rank hold IDXX as of Q2 2018.

  • PEAK6 Group held 7,032 shares of Idexx Laboratories worth $1.53M as of Q2 2018.
  • PEAK6 Group bought 85 Idexx Laboratories shares in Q2 2018, an estimated $17.5K.
  • Idexx Laboratories made up 0.01% of PEAK6 Group's portfolio in Q2 2018, its #1589 holding.
  • PEAK6 Group first reported a position in Idexx Laboratories in Q2 2013 and has held it in 9 quarters since.
  • 664 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.